Samir Hanash

50.4k citations

472 papers · 28.7k indexed · 5 hit papers · h-index 86

Cancer Research top 0.1%
Spectroscopy top 0.05%
- Advanced Proteomics Techniques and Applications 99
- Mass Spectrometry Techniques and Applications 32
Molecular Biology top 0.1%
- Glycosylation and Glycoproteins Research 45
- Advanced Biosensing Techniques and Applications 43
- RNA modifications and cancer 36
- Gene expression and cancer classification 33
Immunology top 0.2%
- Immunotherapy and Immune Responses 27
Oncology top 0.2%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 44

Co-authors: David E. Misek Rork Kuick Thomas J. Giordano John R. Strahler Vítor M. Faça Sharon J. Pitteri David G. Beer Jeremy M. G. Taylor
Cited by: Cancer Research Spectroscopy Molecular Biology
Journals: Cancer Research (30 papers)Proceedings of the National Academy of Sciences (19 papers)PROTEOMICS (17 papers)
Partner nations: United States Japan France

In The Last Decade

Samir Hanash

454 papers receiving 28.1k citations

Hit Papers

5 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2017 Cell Metabolism
2008 Nature
2003 Nature
2002 Nature Medicine
2002 Molecular & Cellular Proteomics

Peers

Countries citing papers authored by Samir Hanash

Since Specialization

Citations

This map shows the geographic impact of Samir Hanash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Hanash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Hanash more than expected).

Fields of papers citing papers by Samir Hanash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir Hanash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Hanash. The network helps show where Samir Hanash may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Samir Hanash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Samir Hanash Line = papers co-authored together Samir Hanash links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Lead time trajectory of blood-based protein biomarkers for detection of pancreatic cancer based on repeat testing Cancer Letters ·Johannes F. Fahrmann,Michele Yip-Schneider,M.F. Roizen,Andhena Wisnu Wardana,Jennifer B. Dennison,Kim‐Anh Do,James P. Long,Anirban Maitra,Jianjun Zhang,Charlie Schmidt,Samir Hanash,Ehsan Irajizad	2025	4
2	NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype Integrative Biology ·Federico Bocci,S. C. Tripathi,Cherin Lim,Jason T. George,I V E T Gomez Periago,Pak Kin Wong,Samir Hanash,Herbert Levine,José N. Onuchic,Mohit Kumar Jolly	2019	104
3	Whole Genome–Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non–Small-Cell Lung Cancer Cancer Research ·Yuanqing Yan,Nan Sun,Hong Wang,Makoto Kobayashi,Jon J. Ladd,James P. Long,Ken C. Lo,Jigar Patel,Eric Sullivan,Thomas Albert,Gary E. Goodman,Kim‐Anh Do,Samir Hanash	2019	15
4	IL22 Promotes Kras -Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties Cancer Immunology Research ·Nasim Khosravi,Mauricio S. Caetano,Amber M. Cumpian,Neşe Ünver,Cynthia De la Garza‐Ramos,建広瀬,Edmund Chada Baracat,Belinda Hernández,Sara Natalia Jaroszewicz,Scott E. Evans,Samir Hanash,Andrei M. Alekseev,Yi Yang,Seon Hee Chang,Roza Nurieva,Humam Kadara,Jichao Chen,Edwin J. Ostrin,Seyed Javad Moghaddam	2018	49
5	MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway Cancer Research ·S. C. Tripathi,Johannes F. Fahrmann,Müge Çeliktaş,Mitzi Aguilar,Kieren D. Marini,Mohit Kumar Jolly,Hiroyuki Katayama,Hong Wang,Eunice Murage,Jennifer B. Dennison,D. Neil Watkins,Herbert Levine,Edwin J. Ostrin,Ayumu Taguchi,Samir Hanash	2017	85
6	Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer Molecular Cancer Research ·Lisa Maria Mustachio,Yun Lu,Laura J. Tafe,Vincent A. Memoli,Jaime Rodriguez‐Canales,Barbara Mino,Pamela Villalobos,Ignacio I. Wistuba,Hiroyuki Katayama,Samir Hanash,Jason Roszik,Masanori Kawakami,Kwang-Jin Cho,John F. Hancock,Azizah Juliani,Shanhu Hu,Xi Liu,Sarah J. Freemantle,Ethan Dmitrovsky	2017	34
7	IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras–Mutant Lung Cancer Cancer Research ·Mauricio S. Caetano,Huiyuan Zhang,Amber M. Cumpian,Lei Gong,Neşe Ünver,Edwin J. Ostrin,Edmund Chada Baracat,Seon Hee Chang,Cesar E. Ochoa,Samir Hanash,Carmen Behrens,Ignacio I. Wistuba,Cinthya Sternberg,Humam Kadara,Carlos Gil Ferreira,Stephanie S. Watowich,Seyed Javad Moghaddam	2016	169
8	Serum Glycans as Risk Markers for Non–Small Cell Lung Cancer Cancer Prevention Research ·L. Renee Ruhaak,Carol Stroble,Jianliang Dai,Matt J. Barnett,Ayumu Taguchi,Gary E. Goodman,Suzanne Miyamoto,D. Gandara,Ziding Feng,Carlito B. Lebrilla,Samir Hanash	2016	21
9	EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape Cancer Research ·Seung-Oe Lim,Chia‐Wei Li,Weiya Xia,Heng‐Huan Lee,Sam S. Chang,Jia Shen,Jennifer L. Hsu,Daniel Raftery,Danijel Djukovic,Haiwei Gu,Wei-Chao Chang,Bennet A. Landman,Mong-Liang Chen,Longfei Huo,Chung‐Hsuan Chen,Yun Wu,Ayşegül A. Şahin,Samir Hanash,Gabriel N. Hortobágyi,Mien‐Chie Hung	2016	203
10	MAPRE1 as a Plasma Biomarker for Early-Stage Colorectal Cancer and Adenomas Cancer Prevention Research ·Ayumu Taguchi,Say Jean Baptiste Anouhe,Qingxiang Yan,Yuzheng Zhang,Yang Zhao,Hanwen Xu,S. C. Tripathi,Hong Wang,Dean E. Brenner,Melanie H. Kucherlapati,Raju Kucherlapati,Adam T. Boutin,Yanru Wang,Ronald A. DePinho,Ziding Feng,Paul D. Lampe,Samir Hanash	2015	26
11	A Search for Novel Cancer/Testis Antigens in Lung Cancer Identifies VCX/Y Genes, Expanding the Repertoire of Potential Immunotherapeutic Targets Cancer Research ·Ayumu Taguchi,Allen D. Taylor,Jaime Rodriguez‐Canales,Müge Çeliktaş,Hui Liu,Xiaotu Ma,Qing Zhang,Chee‐Hong Wong,Alice Chin,Luc Girard,Carmen Behrens,Wan L. Lam,Stephen Lam,John D. Minna,Ignacio I. Wistuba,Adi F. Gazdar,Samir Hanash	2014	36
12	Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition Molecular Cancer Therapeutics ·Kian Kani,Vítor M. Faça,Lindsey D. Hughes,Wenxuan Zhang,Qiaojun Fang,Babak Shahbaba,Roland Luethy,Jonathan Erde,J Ohgushi,Sharon J. Pitteri,Qing Zhang,Jonathan E. Katz,Mitchell E. Gross,Sylvia K. Plevritis,Martin McIntosh,Anjali Jain,Samir Hanash,David B. Agus,Parag Mallick	2012	6
13	Autoantibody Signatures Involving Glycolysis and Splicesome Proteins Precede a Diagnosis of Breast Cancer among Postmenopausal Women Cancer Research ·Jon J. Ladd,Timothy Chao,Melissa M. Johnson,Ji Qiu,Alice Chin,Ana Laura Furlan Blanco,Sharon J. Pitteri,Jianning Mao,Leili Rahmatnezhad,Lynn M. Amon,Martin McIntosh,Christopher Li,Ross L. Prentice,Nana Wang,Samir Hanash	2012	56
14	Concordant Release of Glycolysis Proteins into the Plasma Preceding a Diagnosis of ER+ Breast Cancer Cancer Research ·Lynn M. Amon,Sharon J. Pitteri,Christopher I. Li,Martin McIntosh,Jon J. Ladd,Mary L. Disis,Peggy L. Porter,Chee‐Hong Wong,Qing Zhang,Paul D. Lampe,Ross L. Prentice,Samir Hanash	2012	26
15	Increased Plasma Levels of the APC-Interacting Protein MAPRE1, LRG1, and IGFBP2 Preceding a Diagnosis of Colorectal Cancer in Women Cancer Prevention Research ·Jon J. Ladd,Vaughan Lc,Melissa M. Johnson,Qing Zhang,Sharon J. Pitteri,Hong Wang,Dean E. Brenner,Paul D. Lampe,Raju Kucherlapati,Ziding Feng,Ross L. Prentice,Samir Hanash	2012	79
16	Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial–Mesenchymal Transition in Cancer Cancer Research ·Mark J. Schliekelman,Don L. Gibbons,Vítor M. Faça,Chad J. Creighton,Zain H. Rizvi,Qing Zhang,Chee‐Hong Wong,Hong Wang,Christin Ungewiss,Young‐Ho Ahn,Dong Hoon Shin,Jonathan M. Kurie,Samir Hanash	2011	110
17	Detection of Elevated Plasma Levels of Epidermal Growth Factor Receptor Before Breast Cancer Diagnosis among Hormone Therapy Users Cancer Research ·Sharon J. Pitteri,Lynn M. Amon,Meiqiao Sun,Yuzheng Zhang,Melissa M. Johnson,Alice Chin,Jacob J. Kennedy,Chee‐Hong Wong,ZhongXiang Zhang,Hong Wang,Paul D. Lampe,Ross L. Prentice,Martin McIntosh,Samir Hanash,Christopher I. Li	2010	36
18	Gene Expression Patterns in Mismatch Repair-Deficient Colorectal Cancers Highlight the Potential Therapeutic Role of Inhibitors of the Phosphatidylinositol 3-Kinase-AKT-Mammalian Target of Rapamycin Pathway Clinical Cancer Research ·Eduardo Vilar,Bhramar Mukherjee,Rork Kuick,Leon Raskin,David E. Misek,Jeremy M. G. Taylor,Thomas J. Giordano,Samir Hanash,Eric R. Fearon,Gad Rennert,Stephen B. Gruber	2009	46
19	A biomarker panel for acute graft-versus-host disease Blood ·Sophie Paczesny,Oleg I. Krijanovski,Thomas Braun,Sung Won Choi,Shawn G. Clouthier,Rork Kuick,David E. Misek,Kenneth R. Cooke,Carrie L. Kitko,Angela C. Weyand,Salih Abakah,Dawn Jones,Joel Whitfield,Pavan Reddy,John E. Levine,Samir Hanash,James L.M. Ferrara	2008	290
20	Identification of Novel Alternative Splice Isoforms of Circulating Proteins in a Mouse Model of Human Pancreatic Cancer Cancer Research ·Rajasree Menon,Qing Zhang,Masoum Nazari,Damian Fermin,Nabeel Bardeesy,Ronald A. DePinho,Chunxia Lü,Samir Hanash,Gilbert S. Omenn,David J. States	2008	60

About Samir Hanash

Samir Hanash is a scholar working on Spectroscopy, Cancer Research and Molecular Biology, having authored 472 papers that have together received 28.7k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (99 papers), Glycosylation and Glycoproteins Research (45 papers), Monoclonal and Polyclonal Antibodies Research (44 papers), Advanced Biosensing Techniques and Applications (43 papers), RNA modifications and cancer (36 papers), Gene expression and cancer classification (33 papers), Mass Spectrometry Techniques and Applications (32 papers) and Immunotherapy and Immune Responses (27 papers). The work is most often cited by research in Cancer Research (5.2k citations), Spectroscopy (4.4k citations) and Molecular Biology (17.2k citations). Samir Hanash has collaborated with scholars based in United States, Japan and France. Frequent co-authors include David E. Misek, Rork Kuick, Thomas J. Giordano, John R. Strahler, Vítor M. Faça, Sharon J. Pitteri, David G. Beer, Jeremy M. G. Taylor, Mark B. Orringer and Guoan Chen. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, PROTEOMICS, Cancers and Electrophoresis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact